Casdin Capital, LLC: 13F holdings
CIK 15342612026Q2
| Positions | 43 |
|---|
| Reported value | $2.0bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 43 (+3 vs prior quarter) |
|---|
| Reported value | $2.0bn (+51.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| RVMD REVOLUTION MEDICINES INC | 2,577,333 | $482.7m | 24.2% |
| RLAY RELAY THERAPEUTICS INC | 16,035,240 | $300.0m | 15.0% |
| WGS GENEDX HOLDINGS CORP | 3,707,164 | $254.5m | 12.7% |
| BIOLIFE SOLUTIONS INC | 4,655,000 | $131.5m | 6.6% |
| ILMN ILLUMINA INC | 530,000 | $93.2m | 4.7% |
| LAB STANDARD BIOTOOLS INC | 88,783,856 | $73.0m | 3.7% |
| GPCR STRUCTURE THERAPEUTICS INC | 1,175,000 | $63.1m | 3.2% |
| DNLI DENALI THERAPEUTICS INC | 2,045,000 | $52.6m | 2.6% |
| NGNE NEUROGENE INC | 1,545,361 | $48.6m | 2.4% |
| BEAM BEAM THERAPEUTICS INC | 1,350,000 | $46.3m | 2.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1534261")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples